When receiving the protein-complex ligand, as shown in Figure 2, the highly glycosylated TMEM123 receptor could not only lose the capability of triggering tumor cell apoptosis but also activate downstream protein SYMPK [39,40]. The gene discussed is SYMPK; the disease is neoplasm.